Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 2
1990 2
1992 1
1993 4
1994 2
1995 1
1997 2
1998 4
1999 1
2000 1
2001 2
2002 1
2003 1
2006 1
2007 3
2008 2
2009 1
2010 4
2011 2
2012 3
2013 2
2014 2
2016 3
2017 3
2019 2
2021 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients.
Asberg A, Humar A, Rollag H, Jardine AG, Mouas H, Pescovitz MD, Sgarabotto D, Tuncer M, Noronha IL, Hartmann A; VICTOR Study Group. Asberg A, et al. Among authors: sgarabotto d. Am J Transplant. 2007 Sep;7(9):2106-13. doi: 10.1111/j.1600-6143.2007.01910.x. Epub 2007 Jul 19. Am J Transplant. 2007. PMID: 17640310 Free article. Clinical Trial.
Cytomegalovirus infection in solid organ transplant recipients.
Lumbreras C, Manuel O, Len O, ten Berge IJ, Sgarabotto D, Hirsch HH. Lumbreras C, et al. Among authors: sgarabotto d. Clin Microbiol Infect. 2014 Sep;20 Suppl 7:19-26. doi: 10.1111/1469-0691.12594. Clin Microbiol Infect. 2014. PMID: 26451404 Free article. Review. No abstract available.
Cytomegalovirus in transplantation - challenging the status quo.
Fishman JA, Emery V, Freeman R, Pascual M, Rostaing L, Schlitt HJ, Sgarabotto D, Torre-Cisneros J, Uknis ME. Fishman JA, et al. Among authors: sgarabotto d. Clin Transplant. 2007 Mar-Apr;21(2):149-58. doi: 10.1111/j.1399-0012.2006.00618.x. Clin Transplant. 2007. PMID: 17425738 Review.
Primary breast lymphoma.
Vianello F, Sgarabotto D, Stefani PM, Radossi P, Sartori R, Sartori D, Girolami A. Vianello F, et al. Among authors: sgarabotto d. Forum (Genova). 1998 Apr-Jun;8(2):188-95. Forum (Genova). 1998. PMID: 9925422 Review.
PCR in meningoencephalitis diagnosis.
Sgarabotto D, Buoro S, Mengoli C, Scano F, Cadrobbi P, Di Luca D, Palù G. Sgarabotto D, et al. Scand J Infect Dis. 2000;32(6):689-92. doi: 10.1080/003655400459649. Scand J Infect Dis. 2000. PMID: 11200383
Human cytomegalovirus and Epstein-Barr virus infections occurring early after transplantation are risk factors for antibody-mediated rejection in heart transplant recipients.
Saldan A, Mengoli C, Sgarabotto D, Fedrigo M, Angelini A, Feltrin G, Gambino A, Gerosa G, Barzon L, Abate D. Saldan A, et al. Among authors: sgarabotto d. Front Immunol. 2023 May 15;14:1171197. doi: 10.3389/fimmu.2023.1171197. eCollection 2023. Front Immunol. 2023. PMID: 37256129 Free PMC article.
Oseltamivir-resistant pandemic (H1N1) 2009 treated with nebulized zanamivir.
Da Dalt L, Calistri A, Chillemi C, Cusinato R, Franchin E, Salata C, Sgarabotto D, Toscano G, Gambino A, Palù G. Da Dalt L, et al. Among authors: sgarabotto d. Emerg Infect Dis. 2010 Nov;16(11):1813-5. doi: 10.3201/eid1611.100789. Emerg Infect Dis. 2010. PMID: 21029559 Free PMC article. No abstract available.
53 results